Paperpal Prime Logo

Immunity and Ageing : Impact Factor & More

eISSN: 1742-4933pISSN: 1742-4933
JournalOpen Access

Key Metrics

CiteScore
10.1
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Aging
SNIP
1.46
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Immunity and Ageing

Immunity and Ageing Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2490 | USD 2990 | GBP 2190
Publication Time12
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2004
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in Immunity and Ageing ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Immunity and Ageing

Advances in skin aging: integrating epigenetic, cellular, and immune mechanisms for targeted therapy.
  • 24 Jun 2026
  • Immunity & ageing : I & A
An immune-associated mitochondrial DNA variant with sex differences reveals a putative novel microprotein called MASL.
  • 23 Jun 2026
  • Immunity & ageing : I & A
Insights into the heterogeneity of pneumococcal polysaccharide vaccine immunogenicity in older adults.
  • 2 Jun 2026
  • Immunity & ageing : I & A
Immune risk phenotype and long-term mortality after community-acquired pneumonia in older adults: clinical and immune determinants.
  • 2 Jun 2026
  • Immunity & ageing : I & A
Immunoinflammatory biomarkers for sepsis-associated acute kidney injury: a multicenter prospective cohort study.
  • 18 May 2026
  • Immunity & ageing : I & A
High-dose quadrivalent influenza vaccine in older adults with or without cardiovascular risk: a meta-analysis of randomized trials on 511,890 participants.
  • 9 May 2026
  • Immunity & ageing : I & A
Advances in skin aging: integrating epigenetic, cellular, and immune mechanisms for targeted therapy.
  • 24 Jun 2026
  • Immunity & ageing : I & A
An immune-associated mitochondrial DNA variant with sex differences reveals a putative novel microprotein called MASL.
  • 23 Jun 2026
  • Immunity & ageing : I & A
Insights into the heterogeneity of pneumococcal polysaccharide vaccine immunogenicity in older adults.
  • 2 Jun 2026
  • Immunity & ageing : I & A
Immune risk phenotype and long-term mortality after community-acquired pneumonia in older adults: clinical and immune determinants.
  • 2 Jun 2026
  • Immunity & ageing : I & A
Immunoinflammatory biomarkers for sepsis-associated acute kidney injury: a multicenter prospective cohort study.
  • 18 May 2026
  • Immunity & ageing : I & A
High-dose quadrivalent influenza vaccine in older adults with or without cardiovascular risk: a meta-analysis of randomized trials on 511,890 participants.
  • 9 May 2026
  • Immunity & ageing : I & A

FAQs on Immunity and Ageing